Valuation: Amgen Inc.

Market Cap 196B 172B 158B 146B 278B 18,732B 283B 1,896B 743B 9,199B 737B 721B 31,864B P/E 2026 *
23.8x
P/E 2027 * 21.8x
Enterprise Value 238B 209B 192B 178B 338B 22,751B 343B 2,303B 903B 11,172B 895B 875B 38,699B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 6.02x
Free-Float
99.78%
Yield 2026 *
2.77%
Yield 2027 * 2.93%
1 day-1.19%
1 week-2.81%
Current month+0.41%
1 month+5.53%
3 months+2.26%
6 months+11.51%
Current year+11.09%
1 week 359.47
Extreme 359.4695
375.25
1 month 334.05
Extreme 334.0501
375.25
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 222.27
Extreme 222.27
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-2.81%+22.63%+66.30% 196B
+0.09%+0.25%+54.65%+169.19% 1,085B
-1.63%-1.50%+65.79%+62.70% 624B
-1.12%-4.27%+31.10%+84.44% 442B
+0.18%-1.76%+29.04%+26.51% 332B
-6.22%-8.14%+28.87%+32.09% 277B
-1.27%-2.91%+27.42%+46.39% 282B
-0.93%-3.57%-27.74%-40.38% 217B
-0.72%+2.72%+19.07%+81.19% 167B
+0.83%-0.29%-5.13%-31.75% 138B
Average -1.08%-1.71%+24.57%+49.67% 376.01B
Weighted average by Cap. -0.82%-1.03%+37.33%+80.91%

Financials

2026 *2027 *
Net sales 37.77B 33.04B 30.47B 28.19B 53.51B 3,605B 54.4B 365B 143B 1,770B 142B 139B 6,132B 38.7B 33.85B 31.22B 28.89B 54.83B 3,694B 55.74B 374B 147B 1,814B 145B 142B 6,283B
Net income 8.23B 7.2B 6.64B 6.14B 11.66B 786B 11.86B 79.52B 31.17B 386B 30.9B 30.23B 1,336B 8.86B 7.75B 7.15B 6.62B 12.56B 846B 12.77B 85.64B 33.57B 416B 33.28B 32.56B 1,439B
Net Debt 42.1B 36.83B 33.96B 31.42B 59.64B 4,018B 60.64B 407B 159B 1,973B 158B 155B 6,835B 36.55B 31.98B 29.49B 27.28B 51.79B 3,489B 52.65B 353B 138B 1,713B 137B 134B 5,935B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-09 $363.62 -1.19% 1,728,241
26-07-08 $367.99 -0.03% 1,758,925
26-07-07 $368.10 +0.45% 1,983,666
26-07-06 $366.44 -2.06% 2,838,007
26-07-02 $374.15 +3.55% 2,487,837
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
363.62USD
Average target price
355.66USD
Spread / Average Target
-2.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock